West Virginia will draw more than $826,000 from a multimillion-dollar, multistate settlement with a drug company.
Attorney General Patrick Morrisey announced the settlement Thursday with Cephalon, Teva Pharmaceuticals USA, Teva Pharmaceutical Industries and Barr Laboratories.
Morrisey's news release says the $125 million, 48-state lawsuit claimed Cephalon engaged in anticompetitive practices to protect monopoly profits for its narcolepsy-treating drug, Provigil.
The $826,000 will cover claims, fees and costs. Consumers can make claims for $360,000 in a multistate claims process.
The lawsuit alleged Cephalon defrauded the Patent and Trademark Office to get another patent and delay generic drugs.
The news release says a Federal Trade Commission lawsuit resulted in Cephalon's $1.2 billion settlement fund to cover lawsuits like this one.
The settlement is subject to court review.
Defendants deny wrongdoing through the settlement.
